Literature DB >> 18497673

Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation.

Sue Beath1, Loris Pironi, Simon Gabe, Simon Horslen, Debra Sudan, George Mazeriegos, Ezra Steiger, Olivier Goulet, Jonathan Fryer.   

Abstract

UNLABELLED: Intestinal transplant wait-list mortality is higher than for other organ transplants. The objective of this workshop was to identify the main problems contributing to high mortality in adults and children candidates for intestinal transplantation and provide recommendations on how to correct them. OUTCOME: To facilitate this, 63 relevant articles identified from the medical literature from 1987 to 2007 were reviewed. Consensus was achieved on several important definitions relevant to this review. For children and adults on parenteral nutrition (PN) the main mortality risk factors were identified as were the main risks of mortality for those on the waiting list for intestinal transplants. RECOMMENDATIONS: (1) Primary care givers managing intestinal failure patients should establish a link with an intestinal failure programs early and collaboration with intestinal failure programs should be initiated for patients whose PN requirements are anticipated to be more than 50% 3 months after initiating PN; (2) intestinal failure programs should include both intestinal rehabilitation and intestinal transplantation or have active collaborative relationships with centers performing intestinal transplantation; (3) National registries for intestinal failure patients should be established and organizations that provide home PN solutions should be expected to participate.
CONCLUSION: There are many unresolved issues in adults and children with PN dependent intestinal failure. To address these, a key recommendation of this group is to establish national intestinal failure databases that can support multicenter studies and lead to the adoption of universally accepted standards of patient care with the goal of improving outcomes in all long-term intestinal failure patients including those requiring intestinal transplantation.

Entities:  

Mesh:

Year:  2008        PMID: 18497673     DOI: 10.1097/TP.0b013e31816dd513

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

1.  An Observational Study of Smoflipid vs Intralipid on the Evolution of Intestinal Failure-Associated Liver Disease in Infants With Intestinal Failure.

Authors:  Christina Belza; John C Wales; Glenda Courtney-Martin; Nicole de Silva; Yaron Avitzur; Paul W Wales
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-25       Impact factor: 4.016

Review 2.  Visceral transplantation in patients with intestinal-failure associated liver disease: Evolving indications, graft selection, and outcomes.

Authors:  Jason S Hawksworth; Chirag S Desai; Khalid M Khan; Stuart S Kaufman; Nada Yazigi; Raffaele Girlanda; Alexander Kroemer; Thomas M Fishbein; Cal S Matsumoto
Journal:  Am J Transplant       Date:  2018-04-06       Impact factor: 8.086

Review 3.  Abnormal liver function tests in the parenteral nutrition fed patient.

Authors:  S M Gabe; A Culkin
Journal:  Frontline Gastroenterol       Date:  2010-06-15

4.  Characterization and evolution of intestine injury at the anhepatic phase in portal hypertensive rats.

Authors:  Guijun Ren; Xiaoye Yuan; Xin Zhao; Qingchun Hao; Jinglin Cao; Yang Wang; Qingjun Gao; Jian Dou; Qiang Zeng
Journal:  Exp Ther Med       Date:  2018-09-27       Impact factor: 2.447

5.  Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.

Authors:  Kara L Calkins; James C Y Dunn; Stephen B Shew; Laurie Reyen; Douglas G Farmer; Sherin U Devaskar; Robert S Venick
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-07-26       Impact factor: 4.016

6.  Race affects outcome among infants with intestinal failure.

Authors:  Robert H Squires; Jane Balint; Simon Horslen; Paul W Wales; Jason Soden; Christopher Duggan; Ruosha Li; Steven H Belle
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-10       Impact factor: 2.839

Review 7.  Management of intestinal failure in inflammatory bowel disease: small intestinal transplantation or home parenteral nutrition?

Authors:  Elizabeth Harrison; Philip Allan; Amrutha Ramu; Anil Vaidya; Simon Travis; Simon Lal
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

Review 8.  Current perspectives on pediatric intestinal transplantation.

Authors:  George V Mazariegos; Robert H Squires; Rakesh K Sindhi
Journal:  Curr Gastroenterol Rep       Date:  2009-06

9.  Life-threatening risk factors and the role of intestinal transplantation in patients with intestinal failure.

Authors:  Motoshi Wada; Kotaro Nishi; Megumi Nakamura; Hironori Kudo; Satoshi Yamaki; Hideyuki Sasaki; Tomoyuki Sato; Taichi Fukuzawa; Hiromu Tanaka; Takuro Kazama; Shintaro Amae; Masaki Nio
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

10.  Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab.

Authors:  Alexander Kroemer; Leonid Belyayev; Khalid Khan; Katrina Loh; Jiman Kang; Anju Duttargi; Harmeet Dhani; Mohammed Sadat; Oswaldo Aguirre; Yuriy Gusev; Krithika Bhuvaneshwar; Bhaskar Kallakury; Christopher Cosentino; Brenna Houlihan; Jamie Diaz; Sangeetha Moturi; Nada Yazigi; Stuart Kaufman; Sukanya Subramanian; Jason Hawksworth; Raffaelle Girlanda; Simon C Robson; Cal S Matsumoto; Michael Zasloff; Thomas M Fishbein
Journal:  Am J Transplant       Date:  2020-09-25       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.